Gabapentinoids are specific ligands for the α2δ-1
subunit of voltage-gated calcium channels. This class of drugs, including
gabapentin and pregabalin, exert various pharmacological effects and are widely
used for the treatment of epilepsy, anxiety, and chronic pain. The mechanism of
action of gabapentinoids involves both direct modulation of calcium channel
kinetics and inhibition of channel trafficking and expression, which contribute
to the above pharmacological effects. In the present study, we investigated the
effects of mirogabalin, a novel potent gabapentinoid, on expression levels of
the α2δ-1 subunit in the spinal dorsal horn in a rat
model of spinal nerve ligation (SNL) as an experimental animal model for
peripheral neuropathic pain. The neuropathic pain state was induced by SNL in
male Sprague – Dawley rats. After the development of mechanical
hypersensitivity, the animals received 10 mg/kg mirogabalin or
vehicle orally for 5 consecutive days and were subjected to immunohistochemical
analysis of α2δ-1 subunit expression in the spinal
cord. In the SNL model rats, expression of the α2δ-1
subunit significantly increased in the spinal dorsal horn at the ipsilateral
side of nerve injury, while mirogabalin inhibited this increase. In conclusion,
the α2δ-1 subunit was upregulated in the spinal
dorsal horn of SNL model rats, and repeated administration of mirogabalin
inhibited this upregulation. The inhibitory effect of mirogabalin on
upregulation of the α2δ-1 subunit after nerve injury
is considered to contribute to its analgesic effects in peripheral neuropathic
pain.